Prostate epithelial cells grown embedded in laminin-rich extracellular matrix (lrECM) undergo morphological changes that closely resemble their architecture in vivo. In this study, growth characteristics of three human prostate epithelial sublines derived from the same cellular lineage, but displaying different tumorigenic and metastatic properties in vivo, were assessed in three-dimensional (3D) lrECM gels. M12, a highly tumorigenic and metastatic subline, was derived from the parental prostate epithelial P69 cell line by selection in nude mice and found to contain a deletion of 19p-q13
Introduction
The extracellular environment is essential for establishing and maintaining cell differentiation during glandular morphogenesis (1) . In the developing prostate, budding urogenital epithelial cells attach to the extracellular matrix (ECM) through integrin receptors and migrate into the mesenchyme to form acini containing lumena with established cell polarity (2, 3) . Integrins play an important role in the bi-directional communication between the cell and the ECM, a process essential for the maintenance of tissue morphology and cellular function. Seminal studies using mammary epithelial cells have shown that the balance of integrin levels is a key regulator of cellular behavior (4) . Breast tumor cells, which presented an unbalanced ratio of β1-and β4-integrins, could be restored to a normal cellular phenotype displaying acinar polarity by restoring normal integrin ratios with a blocking β1-integrin antibody (5) . Furthermore, integrin signaling has been implicated in tumor-related signaling through FAK, SRC activation correlating with tumor progression and metastasis (6) . In prostate cancer, tumor stromal interactions have been found to influence cancer progression (7) .
Abnormal stroma containing cancer-associated fibroblasts promoted carcinogenesis of non-tumorigenic, genetically abnormal epithelial cells, but had no effect on normal epithelial cells. Growth of cells in three-dimensional (3D) environments, which better mimic the normal cellular microenvironment, offer unique approaches for elucidating signals that contribute to tumor progression in vivo (8) .
The expression patterns of integrins are known to change during prostate tumor progression. The β1-integrin levels increase in prostate tumor samples, particularly at the cell surface, whereas β2 and β3 remain unchanged (9) . Not only do α-integrins change from α6 to α3 in malignant tumor samples, but a shift in binding partner was detected by the retention of the known laminin-1 receptor, α6β1 and a loss of α6β4 (10) .
Since α6β1 integrin is the leading candidate for conferring invasive potential, it was proposed that inhibition of either α6 or β1 might reverse the invasive phenotype (11) . Furthermore, αvβ3 integrin was shown to be important for the progression of prostate cancer to bone and in IGF-regulated signaling (12, 13) .
Prostate tumors also display a loss of E-cadherin and a switch from intermediate filament proteins (IFP) to vimentin, resulting in loss of hemidesmosomes (11) . Ecadherin and vimentin are known markers for epithelial versus mesenchymal cells, respectively. This switch in expression may reflect cells that have undergone an epithelial to mesenchymal transition (EMT), a process that occurs in reverse (the MET) during embryogenesis, but also during tissue development, e.g., in mammary gland branching (14) . In cancer, the EMT may be a step towards tumor invasion, although this hypothesis remains controversial (15) (16) (17) . However, a role for vimentin in motility has been documented in several cell types and may be important in cancer where motility is one component necessary to establish a metastatic phenotype. Fibroblasts where vimentin expression has been eliminated by gene knockout, fail to move in wound healing studies (18) (19) . In scratch-wound migration assays as well as collagen gel invasion experiments, migration of both breast (MDA-MB-231) and colon (SW480) cancer cells was markedly affected by a 70% reduction in vimentin induced by siRNA approaches (20) . Likewise, reducing vimentin expression in the highly invasive MDA-MB-231 human breast cancer cell line resulted in a dramatic decrease in migratory ability in vitro (21) . MCF7 breast cancer cell lines which lack vimentin are not invasive.
Similar studies in MCF10A cells showed that vimentin is functionally involved in the migratory status of human epithelial cells (22) . Although comparable studies are lacking in prostate, the expression of vimentin may be an underappreciated component of prostate tumor growth and progression.
Normal methods for culturing cells on plastic tissue culture dishes, referred to as two dimensional (2D) do not duplicate the natural milieu surrounding epithelial cells in vivo nor do they produce polarized acini surrounded by basement membrane, as found in normal prostate tissue (23) . To better duplicate growth and differentiation, investigators have begun to culture epithelial cells in 3D laminin-rich ECM gels (lrECM) referred to as Matrigel. Matrigel, prepared from the basement membrane of an EHS (Engelbreth-Holm-Swarm) mouse sarcoma, is highly enriched in laminin plus collagen IV, heparin sulfate proteoglycan, entactin and nidogen (24) . Since cells grown in lrECM gels closely duplicate glandular phenotypic characteristics, these cultures enable an investigation into the influence of ECM and stroma on cell growth and differentiation in vitro (24) (25) (26) .
Such approaches have begun to be applied to a variety of prostate epithelial cell lines grown on top of lrECM gels or on individual ECM components such as laminin or fibronectin alone (27, 28) . For example, the non-tumorigenic prostate epithelial cell line, RWPE-1 immortalized with HPV18 was plated on top of lrECM gels, and it's ability to migrate into-and form branches terminating in-acini was confirmed in 3D cultures (2) .
Similar cultures of RWPE-2, a Ki-ras transformed, tumorigenic subline of RWPE-1, resulted in single to small clumps of cells with no evidence of acinus organization whereas the unrelated human prostatic carcinoma cell line DU-145 formed amorphous balls without organization or lumen (2) . NMU-transformed RWPE-1 cells (WPE1-NB26) formed solid cell masses lacking α6 and β4 integrins with diffuse expression of β1-integrin (29) . On the other hand, normal PNT2-C2 cells grown embedded in lrECM gels formed smooth spheroids of tightly packed cells (28) . The PC-3 cell line (derived from a bone metastasis) formed a mix of both smooth and irregular spheroids, which had a lumen surrounded by a single cell layer (30) . Thus, considerable variability in the morphological structures formed by these different prostate cell lines has been observed. These results could be due to the comparison of genetically dissimilar cell lines or related sublines, which were plated on top of Matrigel rather than embedded.
Due to these inconsistent results, we initiated a more thorough analysis of the morphological structures formed by a unique set of genetically related, malignant or non-malignant prostate sublines grown embedded in lrECM gels.
Prostate epithelial cells were immortalized with SV40 large T-antigen to form a non-metastatic, parental cell line referred to as P69 (31, 32) . The P69 cell line is AR -, does not secrete PSA, but does express cytokeratin 5 and therefore, may have originated from a more basal origin rather than a differentiated luminal epithelial cell. P69 cells were injected subcutaneously into athymic nude mice and after three in vivo passages, a highly metastatic M12 subline was derived (31) . Analysis of M12 chromosomal alterations by GTG-banding and FISH detected a novel 16:19 unbalanced translocation resulting in the deletion of one copy of 19p-q13.1. Microcell-mediated chromosome transfer restored an intact, neomycin-marked human chromosome 19 (Chr19) to generate the F6 subline (33) . The M12 subline is fast growing and highly aggressive whereas the F6 subline is slow growing, barely forms small tumors in athymic nude mice, and is not aggressive. These related sublines present an excellent model for investigating requirements for prostate cancer tumor progression.
Here, the behavior of the cytogenetically related and defined P69, M12 and F6 human prostate epithelial sublines was analyzed in 3D cultures. Under these conditions, we found distinct differences in their morphological properties, which correlated with their behavior in vivo. The non-metastatic P69 cell line forms polarized acini whereas the metastatic M12 subline was highly disorganized with no evidence of polarization. 
Reversion assay. Equal densities of cells were seeded in Matrigel containing
AIIB2 (160 μg/ml), a β1-integrin function-blocking monoclonal antibody, or DMSO as control. After 10 days, cells were photographed and stained with specific antibodies as discussed above.
Results
Morphological properties of P69, M12 and F6 sublines grown embedded in lrECM gels. When grown on plastic tissue culture dishes (2D), the cellular morphology of these prostate cell sublines is indistinguishable (Fig. 1A, top row) . However, when grown embedded in lrECM gels in 3D, these genetically similar sublines organize into distinct, different morphological structures (Fig. 1A , bottom row). The non-tumorigenic P69 epithelial cell line organizes into multicellular spheroids referred to as acini (lane 1).
Although the highly metastatic M12 subline appears to initially try to form acini, within 24
hrs the cells migrate out of these structures and quickly penetrate and spread throughout the Matrigel (lane 2). The poorly tumorigenic F6 subline (M12s with a restored Chr 19) reverts back to forming acini (lane 3). These morphological differences are retained for at least 20 days when cultured in lrECM gels (see Fig. 3 ). Moreover, these morphological differences correlate with the differential behavior of these cells upon subcutaneous or orthotopic injection into male, athymic nude mice (33) . The M12 subline is highly aggressive and metastasizes to lymph nodes, lung and other organs whereas the F6 subline is poorly tumorigenic and does not metastasize.
A proteomic analysis of these sublines revealed a notable difference in the expression of the IFP, vimentin (34) . Epithelial cells grown on plastic tissue culture dishes often aberrantly express vimentin (Fig. 1B , top row) albeit at a low level compared to the cytokeratins, the IFPs normally expressed in epithelial cells in vivo (36) . When grown in 3D, vimentin is not expressed in the P69 subline, akin to expression patterns in vivo (Fig. 1B, bottom row) . Similar to most, if not all metastatic cancers, vimentin is highly expressed in the metastatic M12 subline grown either in 2D or 3D (37) . On the other hand, the amount of vimentin protein is severely reduced in the F6 subline grown under either condition (34) . Thus, in both cases the M12 subline highly expresses vimentin, while the P69 and F6 sublines either do not or exhibit a marked decrease in vimentin expression when grown in lrECM gels.
Blocking vimentin via siRNA interference causes dramatic change in the in vitro phenotype of M12 cells. Previous studies of non-isogenic breast cancer cell lines suggested that vimentin expression is essential, but not sufficient to cause tumor metastasis (38, 39) . In our prostate sublines there is a tremendous difference in the amount of vimentin between the metastatic M12 versus its non-metastatic F6 subline (34) . To determine if vimentin content could have a direct effect on the morphology of the M12 subline, M12s were stably transformed with a vimentin siRNA producing plasmid and designated M12-Vim. When grown as either 2D or 3D the level of vimentin protein was repressed 85% compared to the wild-type M12 (Fig. 1B) . When grown on 2D, there was no apparent difference between the morphology of the M12 versus M12-Vim sublines (Fig. 1A, top row) . However, when grown in 3D the M12-Vim subline reverted to smooth, regular acini-like structures (Fig. 1A, bottom row) . Ki-67 (a proliferation indicator) reveals that nuclei were actively dividing at day 8 ( Fig.   2B , panels a-d). P69 acini do not express vimentin (Fig. 2B, panel a) , but do contain β-catenin (a'), E-cadherin (a"), and α6-, α4-and β1-integrins (Figs. 2C and 2D , panels a and a') akin to normal prostate epithelial cells. The overlay (Figs. 2C and 2D , panel a")
indicates that both α6β4 and α6β1-integrin are co-localized and polarized on the outside edge of the acini as seen in prostate tissue (10, 11, 26) .
In contrast, the metastatic M12 subline did not form acini at day 8 (Figs. 2B, 2C and 2D, panel b). β-catenin staining of cell:cell junctions confirm that these cellular masses are not organized into acini (Fig. 2B, panel b' ). In addition, there is a loss of expression of the epithelial cell marker, E-cadherin ( 2C and 2D, panels a" and c"). These results imply that vimentin expression plays an important role in attaining the disorganized morphology of the M12 subline grown in lrECM gels.
Measurement of growth rate indicates P69, F6 and M12-Vim growth arrest
at day 16. Next, we compared the growth properties of P69, F6 and M12-Vim structures overtime in 3D culture to determine if acini reach a maximum size (cell number), become growth arrested or maintain a lumen (Fig. 3) . Counting the number of nuclei in one hundred P69, F6 and M12-Vim acini indicated these cells are still actively dividing by day 13 in culture ( Fig. 3A) . Growth arrest occurs around day 16, as confirmed by negative staining for Ki-67 at day 16 compared to day 13 (data not shown). The size of the acini (um) also reaches a maximal level by day 16, consistent with the cell number count per acini (Fig. 3B ). This differs from non-malignant human mammary epithelial cells where growth arrest is observed at day 7 in 3D lrECM gels (40) . In contrast, M12 sublines still show positive Ki-67 staining up to day 16. These cultures could not be analyzed past 16 days as the ability of the lrECM gel to support growth becomes rate limiting. Since M12 cells form a non-organized cellular mass rather than acini, it was not possible to count the number of nuclei. with the original Western blots (Fig. 1 ).
Blocking vimentin expression in M12 cells
These in vitro and in vivo results are compiled in Table 1 Inhibiting β1-integrin activity can cause a phenotypic reversion. The inclusion of blocking antibodies for β1-integrin (AIIB2) reverts the M12 cells back to smooth acini-like structures (Fig. 5A ). Similar treatment of the F6 subline shows little effect, although there may be a slight reduction in acini size. Western blots demonstrated that AIIB2 treatment did dramatically decrease β1-integrin expression in both the M12 and F6 sublines, whereas vimentin expression in the M12 subline or actin levels in either subline was not affected by AIIB2 treatment (Fig. 5B) . Immunostaining with the E-cadherin antibody showed that AIIB2 treatment increased E-cadherin expression, resulting in some evidence of polarization akin to F6 acini structures (Fig.   5C , panel b' compared to panels c' and d'). Importantly, AIIB2 had little effect on F6 acini formation. Thus, this affect appears to be specific to the M12 cells. This differs from other studies, where acinar formation of normal prostate epithelium was practically obliterated by the addition of either α6-or β1-blocking antibodies (29), but does agree with the fact that β1-integrin is more associated with the formation of focal adhesion complexes involved with motility than stable hemidesmosomal attachment sites used more for the anchoring of cells. To our knowledge, this is the first time that the effect of β1-integrin function-blocking antibodies has been tested against metastatic prostate cells rather than normal prostate epithelial, a more relevant assay for determining how changes in protein expression contribute to tumor progression.
Discussion
The analysis of multiple membrane and cell surface proteins (E-cadherin, β-catenin, and α6-, β1-, β4-integrins) in these 4 genetically related human prostate epithelial cell lines grown in 3D culture demonstrates that the relative distribution and proportion of cell surface integrins controls the structural homeostasis of these cells.
Moreover, the in vitro expression and distribution of these proteins is functionally related to their behavior in vivo. Thus α6-, β1-and β4 integrin expression is polarized in the non-tumorigenic P69 acini, poorly tumorigenic F6 and M12-Vim acini, but disappears in the disorganized mass of highly tumorigenic and metastatic M12 cells.
The growth of the non-tumorigenic parental P69 cell line in 3D culture produces structures that are morphologically similar to human glandular prostate epithelial cells (2) . With respect to integrins, these acini are polarized and appropriate integrin pairs are co-localized. The metastatic M12 subline escapes from acini formation and quickly spreads throughout the lrECM gel whereas the non-metastatic, barely tumorigenic F6 subline reverts to the production of more normal, polarized acini-like structures. Thus, a thorough analysis of these genetically related sublines has revealed in vitro morphological properties, which correlate with their tumorigenic/metastatic behavior in vivo (31) (32) (33) . These results agree with those previous studies where an inverse relationship was found between acinar formation and malignancy (2, 41) .
Previously, we found that the expression of vimentin was one of the major differences between the M12 and F6 sublines (34) . Recently, a correlation between vimentin expression and degree of metastasis was confirmed in another set of genetically related prostate cells lines (42) . This switch in protein expression suggested that these sublines might be undergoing an EMT transition in vitro, as the gain of vimentin expression with the concomitant loss of E-cadherin has often been used as a biomarker for EMT (15) . More importantly, we found vimentin expression to be a crucial where reversion by the inhibitory β1-integrin antibody or its F(ab') 2 fragment led to the re-establishment of E-cadherin-β-catenin complexes (5) . Here, the interruption of β1-integrin expression did reverse the morphological phenotype of the metastatic M12 subline back to organized, polarized acini as proposed, but never proven experimentally (11) . In our study we detected an actual increase in expression of E-cadherin in the F6 subline compared to M12s or in M12s reverted by the addition of β1-integrin blocking antibodies. Previously, it was suggested that β1-integrin blocking antibodies could represent a relevant therapy to combat tumor progression in metastatic breast cancer (43) . Our results support a similar application to prostate cancer.
Recently, it was postulated that in motile cells vimentin is responsible for moving endocytosed β1-integrin from the rear of the cell to the leading edge under the control of PKC-ε (44) . Upon inhibition of PKC-ε and loss of vimentin phosphorylation, integrins become trapped in endocytic vesicles and directional motility towards the ECM is severely attenuated. Other studies have proposed that vimentin functions as a carrier to move cargo on microtubules using kinesin/dynein motors (45, 46) . Vesicle movement on the IFP network itself has never been documented. Inhibitors that collapse microtubules (MT) also affect the IFP network, suggesting there is cross-talk between MTs and IFs.
Since the IFP network is the only cytoskeletal filament that completely traverses the cytoplasm from the plasma to the nuclear membrane, a role in signal transduction has been proposed (47) . Until now the nature of the cargo carried by vimentin in nonneuronal cells was unknown.
Based on our results and the literature, we propose that vimentin may contribute to moving β1-integrin to the leading edge to support motility in prostate carcinoma (44) .
A direct correlation between vimentin and motility has been suggested in several cell types and in cancer as noted earlier (18, 19, 21, 22) . Blocking β1-integrin antibodies preferentially affected the cellular behavior of metastatic mammary gland cells in 3D culture and in vivo, when injected either subcutaneous or into the fat pad of the mammary gland, whereas non-malignant or normal tissues were not affected (43) .
Prostate carcinoma are positive for α6β1 expression and expression of α6-integrin, β1-integrin's preferred partner, correlates with a more invasive metastatic phenotype (10, 11, 48, 49) . Thus, we propose that vimentin:β1-interaction is crucial for motility, an important precondition for the metastatic property of M12 cells in vivo. Blocking this movement by either blocking β1-integrin via specific antibodies or reducing the amount of vimentin protein via siRNA interference reverts cells to acini-like structures. More importantly, the growth of reverted M12 cells is severely reduced upon subcutaneous injection into nude mice, whereas tumor formation of M12 cells with vector alone or vector expressing a non-targeting siRNA is unaffected. This hypothesis is further supported by the fact it is only the metastatic M12 subline, which expresses both vimentin and β1-integrin, that is highly motile, a required feature for establishing metastasis. We propose that by understanding the nature of the vimentin:β1-integrin interaction, target molecule(s) could be generated to block this interaction. These would be specific for the metastatic cell, since it is only the metastatic cell that expresses both β1-integrin and vimentin. Moreover, this may also produce a relevant target for a variety of other metastatic tumor cells like breast, which also co-express β1-integrin and vimentin at high levels.
In summary, these studies support the concept that the relative distribution and Cells were stained with E-cadherin (green) and β-catenin (red) and nuclei were stained with DAPI (blue). Magnification is at 63X and a size marker of 5 µm is shown.
